SALVE
Study of Alcohol-Related Liver Disease in Europe
A multi-centre European research consortium advancing the understanding, diagnosis, and treatment of alcohol-related liver disease.
About the Consortium
Advancing liver disease research across Europe
SALVE (Study of Alcohol-Related Liver Disease in Europe) is a multi-centre research consortium uniting leading hepatologists, pathologists, and clinical researchers from across Europe. Our collaborative network spans 21 countries and brings together expertise from major university hospitals and research centres.
Our mission is to improve outcomes for patients with alcohol-related liver disease through collaborative research into natural history, pathogenesis, biomarker development, and novel therapeutic approaches. By pooling clinical data and expertise across borders, we aim to accelerate discoveries that translate into better patient care.
SALVE members contribute to landmark studies in hepatology, publishing in top-tier journals and shaping clinical guidelines across the continent. Our work encompasses the full spectrum of alcohol-related liver disease, from early detection and risk stratification to advanced cirrhosis management and liver transplantation.
Collaborative Research
Multi-centre studies pooling clinical data from leading institutions across 21 European countries.
Clinical Innovation
Developing novel biomarkers, treatment strategies, and cost-effective referral pathways.
Knowledge Translation
Turning research findings into clinical guidelines and improved patient outcomes.
Our Network
77 members across Europe
SALVE brings together clinicians and researchers from 21 countries, spanning the continent from Ireland to Ukraine and from Denmark to Portugal.
Western Europe
7 countries
Southern Europe
4 countries
Central & Eastern Europe
9 countries
Northern Europe
1 country
Our People
Steering Committee
Leading hepatologists, pathologists, and clinical researchers from across Europe driving collaborative liver disease research.
Leeds, UK
Richard Parker
Consultant Hepatologist & Honorary Senior Lecturer
Leeds Teaching Hospitals NHS Trust / University of Leeds
Cluj-Napoca, Romania
Horia Stefanescu
Senior Hepatologist
Regional Institute of Gastroenterology and Hepatology, Cluj-Napoca
Barcelona, Spain
Elisa Pose
Hepatologist, Liver Unit
Hospital Clinic of Barcelona
Brussels, Belgium
Christophe Moreno
Professor of Hepato-Gastroenterology
Hopital Universitaire de Bruxelles
Lille, France
Alexandre Louvet
Professor of Hepatology
University Hospital of Lille
Berne, Switzerland
Annalisa Berzigotti
Professor of Clinical Hepatology, Chief of Hepatology
Inselspital, University Hospital of Berne
Athens, Greece
Stratigoula Sakellariou
Histopathologist & Associate Professor
National and Kapodistrian University of Athens
Vienna, Austria
Judith Stift
Pathologist, Hepatobiliary & Pancreatic Pathology
Medical University of Vienna / ZLP Austria
Our Work
Research
SALVE's research priorities and a selection of recent publications co-authored by members of the steering committee.
Research Focus Areas
Natural History of ALD
Characterising disease progression, prognostic factors, and clinical outcomes across the spectrum of alcohol-related liver disease through multi-centre European cohorts.
Diagnostics & Biomarkers
Refining diagnostic criteria for alcohol-associated hepatitis and validating non-invasive markers (including spleen and liver stiffness) for risk stratification.
Histopathology Standardisation
Developing and validating the SALVE histologic grading and staging system for ALD, harmonising pathological assessment across European centres.
Selected Publications
Metabolic dysfunction and alcohol-related liver disease (MetALD): Position statement by an expert panel on alcohol-related liver disease
Arab JP, et al. (incl. Pose, Moreno, Louvet, Stefanescu)
Journal of Hepatology · 2025
Spleen stiffness measurement by vibration-controlled transient elastography at 100 Hz for non-invasive diagnosis of clinically significant portal hypertension
Jachs M, et al. (incl. Stefanescu, Berzigotti); SSM-100Hz/ACLD Study Group
Lancet Gastroenterology & Hepatology · 2024
Adding inflammatory markers and refining NIAAA criteria improve diagnostic accuracy for alcohol-associated hepatitis
Avitabile E, … Pose E (corresponding)
Clinical Gastroenterology and Hepatology · 2023
Quality standards for the management of alcohol-related liver disease: consensus recommendations from the BASL and BSG ARLD special interest group
Parker R, et al.
BMJ Open Gastroenterology · 2023
Development and prognostic relevance of a histologic grading and staging system for alcohol-related liver disease
Lackner C, et al.; SALVE Histopathology Group (incl. Stefanescu, Moreno)
Journal of Hepatology · 2021
Get in Touch
Contact Us
Interested in collaborating or learning more about our research? We'd love to hear from you.